HIV-1 Viral Load by RTPCR

Bacterial/ Viral

Report in 12Hrs

At Home

No Fasting Required

Details

Quantifies viral RNA.

₹2,664₹3,806

30% OFF

HIV-1 Viral Load by RT-PCR - Comprehensive Medical Test Guide

Why is it done?
- Measures the concentration of HIV-1 ribonucleic acid (RNA) in blood plasma, quantifying the amount of viral particles present per milliliter of blood
- Initial diagnosis confirmation in newly diagnosed HIV-1 patients to establish baseline viral burden and disease severity
- Monitor response to antiretroviral therapy (ART) and assess treatment efficacy in HIV-1-positive individuals
- Detect virological failure and emergence of drug-resistant strains during ongoing treatment
- Assess disease progression and predict risk of opportunistic infections and AIDS development
- Evaluate success of viral suppression in patients with undetectable viral loads
- Typically performed at initial HIV diagnosis, every 3-6 months during treatment, and after any treatment modifications
Normal Range
- Reference Range (Negative/Undetectable): <20-40 copies/mL (below the limit of detection, depends on specific assay used)
- Units of Measurement: Copies per milliliter (copies/mL) or log10 copies/mL
- Interpretation of Results:
- Undetectable (<20-40 copies/mL): Indicates successful viral suppression; goal of treatment and associated with improved clinical outcomes
- Detectable (≥20-40 copies/mL): Indicates presence of HIV-1 in circulation; higher levels suggest greater viral replication and infectivity
- Normal vs. Abnormal: In HIV-positive individuals, undetectable is considered 'normal' (successful treatment). In HIV-negative individuals, any detectable level would be abnormal
Interpretation
- Very Low Viral Load (<50 copies/mL): Excellent treatment response; minimal risk of opportunistic infections and disease progression; patient generally not infectious through sexual transmission (Undetectable = Untransmittable)
- Low Viral Load (50-500 copies/mL): Good treatment response but may require closer monitoring; risk of disease progression is significantly reduced
- Moderate Viral Load (500-10,000 copies/mL): Suboptimal treatment response; increased risk of disease progression and development of opportunistic infections
- High Viral Load (10,000-100,000 copies/mL): Inadequate viral suppression; suggests treatment failure, poor medication adherence, or resistant virus; significant risk of disease progression and opportunistic infections
- Very High Viral Load (>100,000 copies/mL): Severe viremia; may indicate acute infection, treatment failure, or severely compromised immune system; high infectivity and rapid disease progression risk; immediate medical intervention required
- Factors Affecting Results:
- Medication adherence - poor compliance leads to higher viral loads
- Presence of drug-resistant HIV strains affecting treatment efficacy
- Recent infections or acute retroviral syndrome causing transient viral load elevation
- Concurrent opportunistic infections causing temporary viral load blips
- Immune status and CD4+ T-cell count influencing viral replication capacity
- Time since initiation or modification of antiretroviral therapy
Associated Organs
- Primary Systems Affected:
- Immune system (CD4+ T-cells, macrophages, dendritic cells) - primary target of HIV-1 infection
- Lymphatic system - site of viral replication and T-cell destruction
- Central nervous system - HIV can cross blood-brain barrier causing neurological complications
- Medical Conditions Associated with Abnormal Results:
- AIDS (Acquired Immunodeficiency Syndrome) - develops when CD4+ counts drop below 200 cells/µL or opportunistic infections occur
- Opportunistic infections (Pneumocystis pneumonia, tuberculosis, cytomegalovirus, toxoplasmosis, candidiasis)
- HIV-associated malignancies (Kaposi sarcoma, non-Hodgkin lymphoma, cervical cancer)
- HIV-associated neurocognitive disorder (HAND) and dementia
- Chronic immune activation leading to accelerated aging and multi-organ dysfunction
- Cardiovascular disease risk increases with elevated viral loads
- Hepatic disease and renal dysfunction related to HIV replication and chronic inflammation
- Potential Complications:
- Rapid disease progression and early mortality if viral load remains uncontrolled
- Increased transmissibility to sexual partners and vertical transmission to infants
- Inflammatory conditions affecting multiple organ systems
Follow-up Tests
- Complementary Testing:
- CD4+ T-cell count - measures immune function and determines need for opportunistic infection prophylaxis
- HIV drug resistance testing (genotypic or phenotypic) - if viral load is detectable despite treatment
- HIV antibody and antigen (p24) testing - for initial diagnosis confirmation
- Complete blood count (CBC) - assesses overall hematologic effects of HIV infection
- Liver and renal function tests - monitor for medication side effects and HIV-related organ involvement
- Lipid panel - assess cardiovascular risk, especially in patients on antiretroviral therapy
- Hepatitis B and C serology - coinfection impacts treatment decisions and prognosis
- Recommended Monitoring Frequency:
- Newly diagnosed patients: Baseline, then every 1-3 months until viral load is undetectable
- Patients on stable ART with undetectable viral load: Every 6-12 months
- Patients with detectable viral load: Every 1-3 months to assess response to regimen changes
- After treatment modifications: Test at 4 weeks post-change, then per standard intervals
- Further Investigations if Needed:
- Tropism testing - determines if virus uses CCR5 or CXCR4 co-receptors for treatment guidance
- Neuroimaging or lumbar puncture - if CNS involvement suspected
- Opportunistic infection screening tests - based on CD4+ count and clinical symptoms
Fasting Required?
- Fasting Requirement: NO
- Fasting is not required for HIV-1 viral load testing. The test can be performed at any time of day regardless of food or beverage intake
- Medications:
- Continue taking all antiretroviral medications as prescribed unless specifically instructed otherwise by the healthcare provider
- Do not skip doses before the test, as this may temporarily increase viral load and provide inaccurate results
- Patient Preparation Instructions:
- Maintain normal daily routine and dietary habits on the day of testing
- Stay well-hydrated; adequate hydration can facilitate blood draw
- Bring identification and insurance information to the blood draw appointment
- Inform the phlebotomist of any recent illnesses or vaccinations, as these may cause temporary viral load fluctuations
- Avoid excessive stress and strenuous exercise immediately before testing, as these may theoretically affect results
- No special preparation is required; standard blood draw protocols apply

How our test process works!